{"artifact":{"id":"experiment-exp-5557bb06-d381-4a86-b164-12e0dd2cc287","artifact_type":"experiment","entity_ids":"[]","title":"Comparison of free-text clinical reports vs Mini-ICF-APP structured assessment","quality_score":0.9,"created_by":"experiment_extractor","provenance_chain":"[]","content_hash":"5eee3c7d38cfce693b1188c457df2fd4ba441d0dcdfe3cda13411e55d1775208","metadata":{"_origin":{"url":null,"type":"internal","tracked_at":"2026-04-10T23:11:22.772876"},"p_value":null,"protocol":"Medical reports from 100 patients were excerpted for psychopathological symptoms and capacity disorders using a checklist. Additionally, structured assessment of capacity disorders was documented using the Mini-ICF-APP rating scale for all patients. Comparison was made between free-text clinical reports and structured assessments.","effect_size":null,"sample_size":100,"source_pmid":"31578018","extracted_at":"2026-04-10T16:11:22.770185","_schema_version":1,"experiment_type":"clinical","success_criteria":"Ability to differentiate between patients fit for work and those unfit for work, and comprehensiveness of capacity impairment identification","expected_outcomes":"Structured assessment would provide more comprehensive evaluation of capacity impairments compared to free-text clinical reports","statistical_methods":"comparative analysis"},"created_at":"2026-04-10T23:11:22-07:00","updated_at":"2026-04-10T23:11:22-07:00","version_number":4,"parent_version_id":null,"version_tag":null,"changelog":null,"is_latest":1,"lifecycle_state":"active","superseded_by":null,"deprecated_at":null,"deprecated_reason":null,"dependencies":null,"market_price":0.5,"origin_type":"internal","origin_url":null,"lifecycle_changed_at":"2026-04-10T23:11:22-07:00","citation_count":0,"embed_count":0,"derivation_count":0,"support_count":0,"contradiction_count":0,"total_usage":0.0,"usage_score":0.5,"usage_computed_at":null,"quality_status":"ok","contributors":[],"answers_question_ids":null,"deprecated_reason_detail":null,"deprecated_reason_code":null,"commit_sha":null,"commit_submodule":null,"last_mutated_at":"2026-05-16T14:51:34.657673-07:00","disputed_at":null,"gap_id":null,"mission_id":null,"intrinsic_priority":null,"effective_priority":null,"artifact_id":"b6785503-0779-4a33-87b0-616bdbdb9f81","artifact_dir":null,"primary_filename":null,"accessory_filenames":null,"folder_layout_version":1,"migrated_to_folder_at":null,"hypothesis_id":null,"authorship":{"kind":"human","contributors":[{"role":"author","actor_ref":"experiment_extractor"}]},"epistemic_tier":"T3_provisional","created_by_agent_id":null},"outgoing_links":[{"target_artifact_id":"wiki-models-app-ps1-dual-transgenic-model","link_type":"related","strength":0.63,"evidence":"Reverse: Gene mention: APP"},{"target_artifact_id":"wiki-mechanisms-app-processing","link_type":"related","strength":0.63,"evidence":"Reverse: Gene mention: APP"},{"target_artifact_id":"wiki-proteins-app","link_type":"related","strength":0.63,"evidence":"Reverse: Gene mention: APP"},{"target_artifact_id":"wiki-diseases-app-mutations-in-ad","link_type":"related","strength":0.63,"evidence":"Reverse: Gene mention: APP"},{"target_artifact_id":"wiki-diseases-app-swedish-mutation","link_type":"related","strength":0.63,"evidence":"Reverse: Gene mention: APP"},{"target_artifact_id":"wiki-mechanisms-app-ps1-double-transgenic-mouse","link_type":"related","strength":0.63,"evidence":"Reverse: Gene mention: APP"},{"target_artifact_id":"wiki-mechanisms-app-bace1-fe65-complex","link_type":"related","strength":0.63,"evidence":"Reverse: Gene mention: APP"},{"target_artifact_id":"wiki-diseases-app-flemish-mutation","link_type":"related","strength":0.63,"evidence":"Reverse: Gene mention: APP"},{"target_artifact_id":"wiki-cell-types-app-overexpressing-neurons","link_type":"related","strength":0.63,"evidence":"Reverse: Gene mention: APP"},{"target_artifact_id":"wiki-diseases-app-arctic-mutation","link_type":"related","strength":0.63,"evidence":"Reverse: Gene mention: APP"},{"target_artifact_id":"wiki-ideas-payload-app-dosage-reduction-ds-therapy","link_type":"related","strength":0.63,"evidence":"Reverse: Gene mention: APP"},{"target_artifact_id":"wiki-entities-app","link_type":"related","strength":0.63,"evidence":"Reverse: Gene mention: APP"},{"target_artifact_id":"wiki-diseases-app-dutch-mutation","link_type":"related","strength":0.63,"evidence":"Reverse: Gene mention: APP"},{"target_artifact_id":"wiki-mechanisms-app-amyloid-beta-plaque-ad-causal-chain","link_type":"related","strength":0.63,"evidence":"Reverse: Gene mention: APP"},{"target_artifact_id":"wiki-mechanisms-app-amyloid-pathway-alzheimers","link_type":"related","strength":0.63,"evidence":"Reverse: Gene mention: APP"},{"target_artifact_id":"wiki-genes-app","link_type":"related","strength":0.63,"evidence":"Reverse: Gene mention: APP"}],"incoming_links":[{"source_artifact_id":"wiki-models-app-ps1-dual-transgenic-model","link_type":"mentions","strength":0.7,"evidence":"Gene mention: APP"},{"source_artifact_id":"wiki-mechanisms-app-processing","link_type":"mentions","strength":0.7,"evidence":"Gene mention: APP"},{"source_artifact_id":"wiki-proteins-app","link_type":"mentions","strength":0.7,"evidence":"Gene mention: APP"},{"source_artifact_id":"wiki-diseases-app-mutations-in-ad","link_type":"mentions","strength":0.7,"evidence":"Gene mention: APP"},{"source_artifact_id":"wiki-diseases-app-swedish-mutation","link_type":"mentions","strength":0.7,"evidence":"Gene mention: APP"},{"source_artifact_id":"wiki-mechanisms-app-ps1-double-transgenic-mouse","link_type":"mentions","strength":0.7,"evidence":"Gene mention: APP"},{"source_artifact_id":"wiki-mechanisms-app-bace1-fe65-complex","link_type":"mentions","strength":0.7,"evidence":"Gene mention: APP"},{"source_artifact_id":"wiki-diseases-app-flemish-mutation","link_type":"mentions","strength":0.7,"evidence":"Gene mention: APP"},{"source_artifact_id":"wiki-cell-types-app-overexpressing-neurons","link_type":"mentions","strength":0.7,"evidence":"Gene mention: APP"},{"source_artifact_id":"wiki-diseases-app-arctic-mutation","link_type":"mentions","strength":0.7,"evidence":"Gene mention: APP"},{"source_artifact_id":"wiki-ideas-payload-app-dosage-reduction-ds-therapy","link_type":"mentions","strength":0.7,"evidence":"Gene mention: APP"},{"source_artifact_id":"wiki-entities-app","link_type":"mentions","strength":0.7,"evidence":"Gene mention: APP"},{"source_artifact_id":"wiki-diseases-app-dutch-mutation","link_type":"mentions","strength":0.7,"evidence":"Gene mention: APP"},{"source_artifact_id":"wiki-mechanisms-app-amyloid-beta-plaque-ad-causal-chain","link_type":"mentions","strength":0.7,"evidence":"Gene mention: APP"},{"source_artifact_id":"wiki-mechanisms-app-amyloid-pathway-alzheimers","link_type":"mentions","strength":0.7,"evidence":"Gene mention: APP"},{"source_artifact_id":"wiki-genes-app","link_type":"mentions","strength":0.7,"evidence":"Gene mention: APP"},{"source_artifact_id":"open_question-46fe4d77-2fcd-422e-9a61-7b7531e8204c","link_type":"partial_answer_for","strength":0.68,"evidence":"{\"confidence\": 0.68, \"judge_persona\": \"domain-expert\", \"model\": \"all-MiniLM-L6-v2\"}"},{"source_artifact_id":"open_question-642754e6-5f66-4f8a-a2c6-efaa408bca05","link_type":"partial_answer_for","strength":0.6,"evidence":"{\"confidence\": 0.6, \"judge_persona\": \"domain-expert\", \"model\": \"all-MiniLM-L6-v2\"}"}],"current_artifact_id":"experiment-exp-5557bb06-d381-4a86-b164-12e0dd2cc287","is_canonical":true,"supersede_chain":["experiment-exp-5557bb06-d381-4a86-b164-12e0dd2cc287"]}